Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response

BACKGROUND: Neutralizing antibodies are considered a key correlate of protection by current SARS-CoV-2 vaccines. The manner in which human infections respond to therapeutic SARS-CoV-2 antibodies, including convalescent plasma therapy, remains to be fully elucidated. METHODS: We conducted a proof-of-...

Descripción completa

Detalles Bibliográficos
Autores principales: Marconato, Maddalena, Abela, Irene A., Hauser, Anthony, Schwarzmüller, Magdalena, Katzensteiner, Rheliana, Braun, Dominique L., Epp, Selina, Audigé, Annette, Weber, Jacqueline, Rusert, Peter, Schindler, Eméry, Pasin, Chloé, West, Emily, Böni, Jürg, Kufner, Verena, Huber, Michael, Zaheri, Maryam, Schmutz, Stefan, Frey, Beat M., Kouyos, Roger D., Günthard, Huldrych F., Manz, Markus G., Trkola, Alexandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2022
Materias:
Clinical Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197521/
https://www.ncbi.nlm.nih.gov/pubmed/35482408
http://dx.doi.org/10.1172/JCI158190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197521/
https://www.ncbi.nlm.nih.gov/pubmed/35482408
http://dx.doi.org/10.1172/JCI158190

Ejemplares similares